| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.25 | 3e-13 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-11 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.21 | 2e-10 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-10 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.2 | 1e-09 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.18 | 6e-09 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.22 | 8e-09 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.17 | 1e-08 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-08 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-08 |